Selective pharmacophore design for α1-adrenoceptor subtypes

Journal of Molecular Graphics and Modelling

Volumn 25, Issue 1, 2006, Pages 146-157

  MacDougall, Iain J A ^a   Griffith, Renate ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

1 Adrenoceptor subtypes; Antagonist; Docking; Pharmacophore; Selectivity

Indexed keywords

Α1-ADRENOCEPTOR SUBTYPES; ANTAGONIST; PHARMACOPHORES; SELECTIVITY;

DRUG PRODUCTS; MATHEMATICAL MODELS; TISSUE;

PROTEINS;

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; PRAZOSIN;

ARTICLE; DRUG DESIGN; PHARMACOPHORE; PRIORITY JOURNAL;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; AMINO ACID SEQUENCE; COMPUTER SIMULATION; DRUG DESIGN; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; RECEPTORS, ADRENERGIC, ALPHA-1; SOFTWARE;

EID: 33747883382     PISSN: 10933263     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmgm.2005.12.001     Document Type: Article

References (57)

1. Civantos Calzada B., and De Artinano A.A. Alpha-adrenoceptor subtypes. Pharmacol. Res. 44 3 (2001) 195-208
2. Klabunde T., and Hessler G. Drug design strategies for targeting G-protein-coupled receptors. ChemBioChem 375 (2002) 261-276
3. 1B-adrenoceptor antagonist. J. Med. Chem. 39 23 (1996) 4602-4607
4. 1 adrenergic receptor subtypes. J. Comput. Aided Mol. Des. 10 6 (1996) 545-547
5. 1-adrenoceptor subtype selective antagonists. Bioorg. Med. Chem. 8 (2000) 201-214
6. 2-adrenoceptors. J. Med. Chem. 44 (2001) 2118-2132
7. 1-adrenoceptor antagonist. J. Chin. Pharm. Sci. 12 4 (2003) 188-191
8. 1-adrenoceptor subtypes. J. Med. Chem. 46 (2003) 2877-2894
9. 1a-adrenoceptor antagonists. Bioorg. Med. Chem. Lett. 15 (2005) 657-664
10. Klabunde T., and Evers A. GPCR antitarget modeling: pharmacophore models for biogenic amine binding GPCRs to avoid GPCR-mediated side effects. ChemBioChem. 6 (2005) 876-889
11. Goodsell D.S., and Olson A.J. Automated docking of substrates to proteins by simulated annealing. Proteins: Str. Func. Genet. 8 (1990) 195-202
12. Morris G.M., Goodsell D.S., Huey R., and Olson A.J. Distributed automated docking of flexible ligands to proteins: parallel applications of AutoDock 2.4. J. Comput. Aided Mol. Des. 10 (1996) 293-304
13. Morris G.M., Goodsell D.S., Halliday R.S., Huey R., Hart W.E., Belew R.K., and Olson A.J. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 19 (1998) 1639-1662
14. 1 adrenoceptor antagonists. J. Med. Chem. 46 (2003) 265-283
15. 1d-adrenoceptors. N.-S. Arch. Pharmacol. 363 (2001) 649-662
16. 1-Adrenoceptor classification: sharpening Occam's razor. Trends Pharmacol. Sci. 15 6 (1994) 167-170
17. 1b-adrenoceptor antagonist. Eur. J. Pharmacol. 287 1 (1995) 13-16
18. 1b-adrenoceptor antagonists. Il Farmaco 58 (2003) 477-487
19. Kenny B., Ballard S., Blagg J., and Fox D. Pharmacological options in the treatment of benign prostatic hyperplasia. J. Med. Chem. 40 9 (1997) 1293-1315
20. 1a adrenergic antagonists. Bioorg. Med. Chem. Lett. 12 (2002) 2443-2446
21. Khatuya H., Pulito V.L., Jolliffe L.K., Li X., and Murray W.V. Novel thiophene derivatives for the treatment of benign prostatic hyperplasia. Bioorg. Med. Chem. Lett. 12 (2002) 2145-2148
22. King H.K., Goetz A.S., Ward S.D.C., and Saussy Jr. D.L. Soc. Neuro. Abs. 20 (1994) 526
23. Konkel M.J., Wetzel J.M., Cahir M., Craid D.A., Branchek T.A., Noble S.A., and Gluchowski C. Discovery of antagonists selective for the alpha 1D-adrenoceptor. Book of Abstracts, 216th ACS National Meeting, MEDI-129. Boston, August 23-27 (1998)
24. 1a-adrenergic receptor antagonists. J. Med. Chem. 43 11 (2000) 2183-2195
25. 1a-adrenergic receptor antagonist. Bioorg. Med. Chem. 8 (2000) 2263-2275
26. 1d-adrenergic receptor. J. Med. Chem. 47 (2004) 1900-1918
27. 1-adrenergic receptor antagonists. Bioorg. Med. Chem. Lett. 10 (2000) 1093-1096
28. 1-adrenergic receptor antagonists. Bioorg. Med. Chem. Lett. 10 (2000) 2375-2377
29. 1b-adrenergic receptor antagonist. J. Med. Chem. 41 8 (1998) 1205-1208
30. 1-adrenergic receptors. Bioorg. Med. Chem. Lett. 6 17 (1996) 2103-2106
31. 1-adrenoceptors. J. Med. Chem. 46 (2003) 4895-4903
32. Testa R., Guarneri L., Angelico P., Poggesi E., Taddei C., Sironi G., Colombo D., Sulpizio A.C., Naselsky D.P., Hieble J.P., and Leonardi A. Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): role of the alpha-1L adrenoceptor in tissue selectivity, part II. J. Pharmacol. Exp. Ther. 281 3 (1997) 1284-1293
33. Catalyst 4.9 User Guide and On-line Help (2003), Accelrys Inc., San Diego, CA, USA
34. Smellie A., Teig S.L., and Towbin P. Poling: promoting conformational variation. J. Comp. Chem. 16 (1995) 171-187
35. Smellie A., Kahn S.D., and Teig S.L. Analysis of conformational coverage 1. Validation and estimation of coverage. J. Chem. Inf. Comp. Sci. 35 (1995) 285-294
36. Smellie A., Kahn S.D., and Teig S.L. Analysis of conformational coverage 2. Applications of conformational models. J. Chem. Inf. Comp. Sci. 35 (1995) 295-304
37. 1-adrenoceptor antagonists: a chemometric study. J. Mol. Struct. (Theochem) 331 1-2 (1995) 79-93
38. 1-adrenergic receptor ligands. J. Mol. Struct. (Theochem) 305 (1994) 101-110
39. 1-adrenergic antagonists. J. Mol. Struct. (Theochem) 276 (1992) 327-340
40. Peitsch M. Protein modeling by E-mail. Biotechnology 13 (1995) 658-660
41. Peitsch M. ProMod and Swiss-Model: internet-based tools for automated comparative protein modelling. Biochem. Soc. Trans. 24 (1996) 274-279
42. Geux N., and Peitsch M. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modelling. Electrophoresis 18 (1997) 2714-2723
43. Oliveira L., Hulsen T., Lutje Hulsik D., Paiva A.C.M., and Vriend G. Heavier-than-air flying machines are impossible. FEBS Lett. 564 3 (2004) 269-273
44. Li H., Sutter J., and Hoffmann R. HypoGen: an automated system for generating 3D predictive pharmacophore models. In: Guner O. (Ed). Pharmacophore Perception, Development, and Use in Drug Design (2000), International University Line, La Jolla, CA, USA 171-187
45. Sutter J., Guner O., Hoffmann R., Li H., and Waldman M. Effect of variable weights and tolerances on predictive model generation. In: Guner O. (Ed). Pharmacophore Perception, Development, and Use in Drug Design (2000), International University Line, La Jolla, CA, USA 501-511
46. 1-adrenoceptor binding affinity. J. Mol. Struct. (Theochem) 233 (1991) 343-351
47. 1 antagonist WB-4101. Bioorg. Med. Chem. 12 (2004) 4937-4951
48. 1A-adrenoceptor subtype. Br. J. Pharmacol. 119 8 (1996) 1563-1568
49. 1-Adrenoreceptor antagonists bearing a quinazoline or a benzodioxane moiety. Pharm. Acta Helv. 74 2-3 (2000) 181-190
50. 1a-adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia. J. Med. Chem. 44 (2001) 1971-1985
51. 1a-adrenergic receptor subtype-selective antagonists. J. Pharmacol. Exp. Ther. 294 1 (2000) 224-229
52. 1-adrenoreceptor subtypes. J. Med. Chem. 45 8 (2002) 1633-1643
53. 1d receptor. Bioorg. Med. Chem. Lett. 11 (2001) 1119-1121
54. 1-adrenoceptor subtype selectivity: molecular modelling and theoretical quantitative structure-affinity relationships. Bioorg. Med. Chem. 5 5 (1997) 809-816
55. Ko F.N., Guh J.H., Yu S.M., Hou Y.S., Wu Y.C., and Teng C.M. (-)-Discretamine, a selective alpha 1D-adrenoceptor antagonist, isolated from Fissistigma glaucescens. Br. J. Pharmacol. 112 4 (1994) 1174-1180
56. Laskowski R.A., MacArthur M.A., Moss D.S., and Thornton J.M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26 (1993) 283-291
57. 1B-adrenergic receptor highlight the role of the helix 3/helix 6 interface in receptor activation. Mol. Pharmacol. 61 5 (2002) 1025-1032